In a study of 10 patients, the LYNX LIO achieved a mean treatment time of 16 minutes, 43 seconds, with 3,489 spots delivered ...

NASA’s development of autonomous eye imaging technologies for astronauts aboard the International Space Station is paving the ...

Funding will support the continued clinical advancement of its lead ocular implant candidate, PA5108, for the reduction of ...

EssilorLuxottica and MidEuropa recently entered into an agreement that will allow EssilorLuxottica to acquire Optegra, ...

The rationale for the study under discussion is that the experience level of the operating surgeon is a potential factor ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Advanced autofluorescence reveals cellular pigment reservoirs with therapeutic potential at the 2025 International Spectralis Symposium – and Beyond.

Cabozantinib is a vascular endothelial growth factor receptor tyrosine kinase inhibitor, a drug used as a therapy for several ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Siegfried Priglinger, MD discussed research he presented focused on pediatric patients with inherited retinal diseases with ...